Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04112576 · ClinicalTrials.gov registry record
Physiological Signals, Activity and Posture for Surface Mounted Insertable Cardiac Monitor in Heart Failure Study
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 100
- Enrollment target
NCT04112576: Completed study, sponsored by Boston Scientific Corporation.
NCT04112576 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04112576 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
To characterize the physiological signals collected from a Wearable Cardiac Monitor (WCM) prototype device in subjects with heart failure and preserved ejection fraction (HFpEF) and compare against signals from subjects with heart failure and reduced ejection fraction (HFrEF). To evaluate the relationship of physiological signals measured from a wearable cardiac monitor (WCM) prototype device with ECHO measures of systolic and diastolic function
Primary Outcome
Characterize differences in cardiac physiology and dynamics between heart failure with preserved ejection fraction and heart failure with reduced ejection fraction patient populations using a wearable cardiac monitor prototype device.
Interventions
- DEVICE Wearable cardiac monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-07-23 |
| Est. Completion | 2022-05-11 |
What the finished NCT04112576 record still lists
NCT04112576 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Wearable cardiac monitor is the first listed.
NCT04112576 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04112576 about?
NCT04112576 is a clinical study titled "Physiological Signals, Activity and Posture for Surface Mounted Insertable Cardiac Monitor in Heart Failure Study". To characterize the physiological signals collected from a Wearable Cardiac Monitor (WCM) prototype device in subjects with heart failure and preserved ejection fraction (HFpEF) and compare against signals from subjects with heart failure and reduced ejection fraction (HFrEF). To evaluate the relat...
What is the current status of trial NCT04112576?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2020-07-23. Estimated completion is 2022-05-11.
What interventions are being tested in trial NCT04112576?
The interventions under investigation include: Wearable cardiac monitor (DEVICE).
Who is sponsoring clinical trial NCT04112576?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI